The study compared improvements in frontal lobe dysfunction induced by rTMS and improvement of white matter integrity revealed by diffusion tensor imaging in patients with TRD receiving rTMS treatment.
The combination of higher serum oxLDL and LDL levels was found to be associated with an increased risk for recurrent stroke and poor functional outcomes in patients who have had minor stroke or are at high risk for TIAs.
Study further highlights the need to use precise and accurate depression and anxiety scales adjusted to patients not only for assessment purposes but also for the treatment of these symptoms in obstructive sleep apnea.
The influence of gut microbiota extends to the brain via neuroinflammation, resulting in symptoms associated with major depressive disorder.
Rapid eye movement-related obstructive sleep apnea and other sleep disordered breathing events are associated with an increased risk for gestational diabetes.
Atomoxetine plus oxybutynin demonstrated efficacy in improving upper airway collapsibility, increasing breathing stability, and reducing the threshold for arousal in obstructive sleep apnea.
No difference was seen in the risk for serious neuropsychiatric events in patients who received oseltamivir in the 30 days after influenza diagnosis compared with those who did not.
A network of gut bacteria species may be associated with host genetic factors that increase susceptibility to multiple sclerosis.
More patients with early relapsing-remitting multiple sclerosis (RRMS) treated with natalizumab experienced confirmed disability improvement than disability worsening.
The onset of hyperlipidemia may occur earlier in patients with multiple sclerosis.
